OGN
Organon & Co
NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$13.87
+0.58% today
Updated 2026-11-06
Market cap
$3.63B
P/E ratio
17.71
P/S ratio
0.59x
EPS (TTM)
$0.78
Dividend yield
0.58%
52W range
$6 – $14
Volume
2.5M
Organon & Co (OGN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.87
12-Month target
$4.88
2030 Target
—
Intrinsic (DCF)
$12.11
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $6.3B | $6.2B | $6.3B | $6.4B | $6.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 17.71x (capped 25x) · Margin: 3.41%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.